Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01266460
Recruitment Status : Active, not recruiting
First Posted : December 24, 2010
Last Update Posted : August 24, 2017
Advaxis, Inc.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Gynecologic Oncology Group

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : October 2, 2018
  Study Completion Date : No date given